You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of a Novel PolC Inhibitor as a Gram-Positive Antibiotic
SBC: CRESTONE, INC. Topic: NIAIDDESCRIPTION (provided by applicant): The alarming increase in incidence of infections caused by drug-resistant bacteria has created an urgent need for new antibacterial agents. We are developing a novel class of small molecule antibiotics ( TZUs ) targeting PolC, the replicative DNA polymerase in Gram-positive bacteria. These agents exhibit broad-spectrum activity against Gram-positive bacteria, ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION (provided by applicant): Development of radiological/nuclear medical countermeasures to treat Acute Radiation Syndrome (ARS) is a high priority research area for NIAID. Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure, often resulting i death. Granulocyte colony-stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Micro_patterned Surfaces for Reducing the Risk of Ventilator_Associated Pneumonia
SBC: Sharklet Technologies Inc. Topic: NHLBIDESCRIPTION (provided by applicant): Ventilator-associated pneumonia (VAP) is the most costly and second most common hospital-acquired infection (HAI), accounting for over 86% of hospital-acquired pneumonia (HAP). Some 300,000 HAP patients are treated annually in the U.S., at an estimated annual hospital cost of more than 1.5 billion. The current paradigm for preventing VAP has been to implement ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials
SBC: PHARMATECH, INC. Topic: NCIDESCRIPTION (provided by applicant): The American Cancer Society estimates that more than 1.5 million new cancer victims will be diagnosed this year in the U.S., and that ~572,000 Americans will die of cancer in 2011.1 More than 13 million Americans are living today with a history of cancer, and this number is heading toward 18 million by 2020.1 Beyond the human costs in lives, productivity, and q ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Low Cost Laser Diagnostic for CD4+ T Cell Counting
SBC: MBIO DIAGNOSTICS INC Topic: NIAIDDESCRIPTION (provided by applicant): The overall goal of this project is to develop and commercialize a simple cell counter for routine enumeration of CD4 cells for management of HIV-infected individuals. HIV-1 mediated CD4 cell destruction is the centralimmunologic feature of HIV-1 infection. Thus, the CD4 count is a critical measurement in initial disease staging, in monitoring antiretroviral t ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Conversations About cancer (CAC): A Theatrical Production
SBC: KLEIN BUENDEL, INC. Topic: NCIDESCRIPTION (provided by applicant): Findings from our Phase I feasibility study reveal strong impacts of a theatrical production we have developed entitled Conversations about Cancer (CAC): A play in which all dialogue is drawn from naturally occurring (transcribed) interactions between family members as they navigate their way through the trials and tribulations, hopes and triumphs of a cancer ...
STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Computerized Stage-Matched Intervention for Juvenile Offenders
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDADESCRIPTION (provided by applicant): Juvenile crime imposes enormous costs on victims, on society, and on juvenile offenders themselves. However, research assessing the efficacy of interventions for young offenders show, on average, only small effects on recidivism, substance abuse, and other behavioral outcomes. A major problem with existing interventions is that they tend to neglect individual d ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Robust, defined, animal-free cell culture medium for the production of vaccines
SBC: VENTRIA BIOSCIENCE Topic: NIAIDDESCRIPTION (provided by applicant): The Vero cell line is used in the production of viral based vaccines. The use of cell based vaccines based on the Vero cell line is growing. The majority of the vaccines in use today are produced using cell culture medium supplemented with serum. The use of animal-derived products in vaccine culture media presents a risk for the transmission of infectious disea ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Demonstration of 2.5kW/10kWh Vanadium Redox Flow Battery (VRFB) through rationally designed high energy density electrolytes and Membrane-Electrode Assembly (MEA)
SBC: ITN ENERGY SYSTEMS, INC. Topic: 1ITN Energy Systems, Inc. (ITN) is proposing demonstration and deployment of 2.5kW/10kWh Vanadium Redox Flow Battery (VRFB) technology through a multi-faceted effort based on 1) Novel V-electrolytes based on Fluorinated Carboxylates, 2) Low-cost (and superior) proton exchange membrane and 3) “zero-gap” membrane-electrode assembly. The Fluorinated V-carboxylates are a new class of V-salts with t ...
SBIR Phase II 2012 Department of EnergyARPA-E